Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Agriculture-focused data science company Fermata secured $10 million while vertical farming company Plenty faces a value cut.

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Portage: Stryker, a medical technologies company, has announced a definitive agreement to acquire all of the issued and ...

The latest health news highlights Trump considering an executive order to protect gas stoves, warnings for GSK's and Pfizer's ...

Fintel reports that on January 7, 2025, Wells Fargo downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...